UA83988C2 - Моноклональное антидвойное интегриновое антитело, которое специфически связывает человеческие интегрины альфа v бета 3 и альфа v бета 5, фармацевтическая композиция, которая его содержит, и их применение в терапии - Google Patents
Моноклональное антидвойное интегриновое антитело, которое специфически связывает человеческие интегрины альфа v бета 3 и альфа v бета 5, фармацевтическая композиция, которая его содержит, и их применение в терапииInfo
- Publication number
- UA83988C2 UA83988C2 UA2003021153A UA2003021153A UA83988C2 UA 83988 C2 UA83988 C2 UA 83988C2 UA 2003021153 A UA2003021153 A UA 2003021153A UA 2003021153 A UA2003021153 A UA 2003021153A UA 83988 C2 UA83988 C2 UA 83988C2
- Authority
- UA
- Ukraine
- Prior art keywords
- beta
- alpha
- integrines
- therapy
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Изобретение принадлежит к моноклональному антителу человека, которое специфически связывает человеческие интегрины Альфа V Бета 3 (αβ) та Альфа V Бета 5 (αβ), фармацевтической композиции, которая его содержит, и их применение в терапии, при производстве лекарственного средства для лечения или предотвращения расстройств, опосредованных интегринами αβта αβ, в частности, для лечения злокачественных заболеваний.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22336300P | 2000-08-07 | 2000-08-07 | |
US92026701P | 2001-08-01 | 2001-08-01 | |
PCT/US2001/024784 WO2002012501A2 (en) | 2000-08-07 | 2001-08-07 | Anti-dual integrin antibodies, compositions, methods and uses |
Publications (1)
Publication Number | Publication Date |
---|---|
UA83988C2 true UA83988C2 (ru) | 2008-09-10 |
Family
ID=50724194
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UA2003021153A UA83988C2 (ru) | 2000-08-07 | 2001-08-07 | Моноклональное антидвойное интегриновое антитело, которое специфически связывает человеческие интегрины альфа v бета 3 и альфа v бета 5, фармацевтическая композиция, которая его содержит, и их применение в терапии |
Country Status (3)
Country | Link |
---|---|
CY (1) | CY1110755T1 (ru) |
MY (1) | MY155265A (ru) |
UA (1) | UA83988C2 (ru) |
-
2001
- 2001-08-07 MY MYPI20013704A patent/MY155265A/en unknown
- 2001-08-07 UA UA2003021153A patent/UA83988C2/ru unknown
-
2010
- 2010-08-27 CY CY20101100786T patent/CY1110755T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CY1110755T1 (el) | 2015-06-10 |
MY155265A (en) | 2015-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL267381A (en) | A pharmaceutical preparation containing dextromethorphan and quinidine for the treatment of nervous disorders | |
DE60028970D1 (de) | An her2 bindende peptidverbindungen | |
BG110703A (en) | PHARMACEUTICAL COMPOSITION, INCLUDING HUMAN ANTIBODIES CONNECTING HUMAN TNF ALPHA AND HIS APPLICATION | |
YU37602A (sh) | Derivat pirolidinacetamida sam ili u kombinaciji za tretman poremećaja cns | |
AU4550801A (en) | Herbal composition phy906 and its use in chemotheraphy | |
WO2004005326A3 (de) | Tubulysinkonjugate | |
BG66083B1 (bg) | Фармацевтични състави, съдържащи антитела и антитела за профилактика и лечение на амилоидогенно заболяване | |
MXPA03005340A (es) | Nuevas composiciones de medicamentos a base de anticolinergicos y ciclesonida. | |
EP0797999A3 (en) | Formulations of obesity protein | |
GR3035762T3 (en) | Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses | |
NZ328874A (en) | Heterocyclic biaryl compounds and their use in pharmaceutical compositions for treatment of dermatological, rheumatic, respiratory, cardiovascular and ophthalmological disorders | |
HUP0400153A2 (en) | Product comprising mikanolide, dihydromikanolide or an analogue thereof combined with another anti-cancer agent for therapeutic use in cancer treatment | |
TR200100637T2 (tr) | Yeni doğal ürün türevleri | |
GB9509888D0 (en) | Terpenoidic derivatives useful as antitumour agents | |
EE200100689A (et) | IL6RIL6 kimääri kasutamine ravimi valmistamiseks,mis on ette nähtud neuroloogiliste haiguste ravimiseks, ning farmatseutiline kompositsioon | |
RS60604A (en) | Carboxamidine derivatives and their use in the treatment of vascular diseases | |
WO2002066492A3 (fr) | Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques. | |
UA83988C2 (ru) | Моноклональное антидвойное интегриновое антитело, которое специфически связывает человеческие интегрины альфа v бета 3 и альфа v бета 5, фармацевтическая композиция, которая его содержит, и их применение в терапии | |
GB0312566D0 (en) | Veterinary composition for the topical treatment of traumatized or inflamed skin | |
PL375354A1 (en) | Use of treosulfan and derivatives thereof for treating multiple sclerosis | |
ECSP993206A (es) | Metodo para mejorar la farmacocinetica del tipranavir | |
WO2002102849A3 (en) | Bcmp-101, a cancer associated protein |